ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human TumorsAlex I. Zaika, Ute M. Moll, Michael L. Pearl et al.|The Journal of Experimental Medicine|2002Cited by 317
Transdominant ΔTAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors <b> <i>in Vivo</i> </b>Nicole Concin, Ute M. Moll, K Becker et al.|Cancer Research|2004Cited by 137
ΔNp73 stabilises TAp73 proteins but compromises their function due to inhibitory hetero-oligomer formationNeda Slade, Ute M. Moll, Alexander Zaika et al.|Cell Death and Differentiation|2003Cited by 38